StockWatch
·
Q2 FY-2027 RESULTS · SUPRAJIT

Suprajit Q2: consol PAT +5% YoY on 21% revenue growth as standalone profit falls 23%

PAT +4.75% YoY · revenue +20.63% · margins expanding

Q2 FY27 resultsSUPRAJITSUPRAJIT ENGINEERING LTD.-$07 Nov 2026 · 3 min read
Revenue

₹1,135.14 Cr

+20.63% YoY

PAT (consolidated)

₹53.37 Cr

+4.75% YoY

Net margin

4.68%

-0.5pp YoY

EPS

₹3.89

Suprajit's consolidated revenue rose 20.6% YoY (6.1% QoQ) to ₹1,135.14 Cr in Q2 FY27, while consolidated PAT grew a much more modest 4.8% YoY (2.2% QoQ) to ₹53.37 Cr, EPS ₹3.89 versus ₹3.71 a year ago. The headline verdict is inline rather than clearly strong: top-line growth and operating margins moved in the right direction, but reported bottom-line growth lagged revenue by a wide margin, and the standalone (India) business told a weaker story on its own — standalone PAT fell 23.2% YoY to ₹67.96 Cr even as standalone revenue grew 15.8% YoY to ₹564.37 Cr, a divergence from the consolidated print that readers should note explicitly.

The scoreboard

Q2 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹1,135.14 Cr+6.1%+20.6%
Expenses₹1,054.29 Cr+5.7%+17.9%
PAT₹53.37 Cr+2.18%+4.75%
Net margin4.68%-0.2pp-0.5pp
EPS₹3.89+2.4%+4.9%

The margin bridge explains the gap between strong revenue growth and muted PAT growth. Consolidated operating margin (OPM, EBITDA basis) expanded to 12.20% from 10.58% a year ago and from 12.03% in Q1 FY27, tracking comfortably inside management's 12–13.5% FY27 EBITDA guidance band. But net margin looks flat-to-down (4.69% of total income versus 5.22% a year ago) because Q2 FY26's other income was an outsized ₹34.7 Cr versus just ₹4.0 Cr this quarter and ₹4.2 Cr in Q1 FY27 — a high base effect rather than a core profitability issue. Separately, the four subsidiaries reviewed by other auditors (tied to the Stahlschmidt Cable Systems integration in Germany/Canada/China) posted a combined net loss of ₹28.28 Cr for the quarter, widening from an implied ₹19.3 Cr loss in Q1 FY27 (H1 FY27 disclosed loss: ₹47.59 Cr) — a continuing drag on group profitability even as the standalone business alone remains solidly profitable.

₹
442.49467.06491.63516.19540.76481.908-0408-2609-1810-1311-0511-06
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹481.9, up 4.2% over the past month of trading.

₹ Cr
024.6449.2773.9148.09Q1 FY26rev ₹863 Cr50.95Q2 FY26rev ₹941 Cr12.53Q3 FY26rev ₹979 Cr65.99Q4 FY26rev ₹468 Cr52.23Q1 FY27rev ₹1,070 Cr53.37Q2 FY27rev ₹1,135 Cr
Quarterly consolidated PAT, ₹ Crore

For context: this is the second-highest quarterly PAT of the last 6 quarters; revenue is at a 6-quarter high.

What management guided (1 FY-2027 call)
FY27 double-digit consolidated revenue growth with EBITDA margin 12–13.5% (maintained from May 2026). GCM targeting 10–12% margin operationally; ICM and PLE expected to recover in Q2–Q3 post wage pass-through.

— This quarter: met

Against guidance, the print is a clear meet: management's FY27 ask was double-digit consolidated revenue growth with 12–13.5% EBITDA margin, and both were met this quarter (20.6% YoY revenue, 12.20% OPM). We found no independent analyst consensus estimate specifically for this quarter, so vsStreet is marked unknown; the closest available read is management's own pre-quarter commentary of "over 20% growth" in the global business, which the 20.6% YoY print satisfies. On the domestic side, the prior concall flagged ICM and PLE margin recovery "post wage pass-through" for Q2–Q3 — standalone PBT actually fell 19.6% YoY this quarter, so that recovery has not yet shown up in the numbers and bears watching into Q3. No separate management press release was available for this filing beyond the regulatory board-outcome letter, which otherwise only confirms the result approval, an independent director appointment (Dr. Steffen Berns, effective Jan 1, 2027), and routine items (a 7.38-lakh SAR grant and a ₹38.4-lakh solar investment) that carry no bearing on this quarter's numbers.

  • W1

    Domestic ICM/PLE margin recovery guided "post wage pass-through" for Q2–Q3 FY27 — standalone PBT was still down 19.6% YoY this quarter, so Q3 standalone numbers are the test

  • W2

    Subsidiary losses (4 entities under other-auditor review) widened to ₹28.28 Cr this quarter from ~₹19.3 Cr in Q1 FY27 — watch whether this stabilizes as SCS integration matures

  • W3

    FY27 guidance of double-digit consolidated revenue growth and 12–13.5% EBITDA margin — both were met this quarter (20.6% revenue growth, 12.20% OPM); watch if the margin trend holds through H2

Informational and educational content only. Not investment advice.